by nikki mann | Sep 9, 2024 | News
We are delighted that the Milner Therapeutics Institute (MTI) has joined a three-year collaboration with the science funding agency ARIA and multiple Cambridge partners, to engineer a new generation of neuro-technologies designed to treat depression, dementia, chronic...
by nikki mann | Aug 1, 2024 | News
We’re delighted to announce that the Medical Research Council (MRC), in collaboration with the Biotechnology and Biological Sciences Research Council (BBSRC), awarded £7m to help establish the MRC-AstraZeneca-University of Cambridge joint Functional Genomics...
by nikki mann | Jul 15, 2024 | News
Earlier this year, our Head of Research Dr Nicola McCarthy sat down with Megan Thomas, Multimedia Editor at Drug Discovery World, to explore Nicola’s role at the MTI, her career journey, and her views on the current opportunities and challenges in the field of drug...
by nikki mann | Jul 11, 2024 | News
Global life sciences leader and Milner affiliate Cytiva recently established a footprint in the Jeffrey Cheah Biomedical Centre on the Cambridge Biomedical Campus (CBC), further developing relationships with the Milner Institute and the Cambridge Stem Cell Institute...
by nikki mann | Jul 7, 2024 | News
Last week, we were delighted to host two sell-out events in Cambridge that brought academics, investors, pharma and biotech companies together. On 1st July, we hosted our Milner Pitch Day at St Catharine’s College, which aimed to accelerate innovative ideas toward...
by nikki mann | Jun 20, 2024 | News
We were delighted to welcome Flagship Pioneering to the Milner Therapeutics Institute this week. Noubar Afeyan and colleagues from Flagship visited the Institute to learn more about the Milner model and discuss how we might work together in future. It was fantastic to...
